Efficacy outcomes | Number (%) of patients |
---|---|
Assessment of SCIG therapy by investigator | (N = 61) |
Excellent | 54 (89) |
Acceptable | 6 (10) |
Insufficient | 1 (2) |
Final assessment of therapy by investigator | (N = 61) |
Easy to learn and well feasible | 50 (82) |
Learnable and feasible | 9 (15) |
Too hard to learn as home therapy | 2 (3) |
Final assessment of therapy by patient | (N = 44) |
Gives more flexibility than IVIG | 38 (86) |
Gives the same flexibility as IVIG | 4 (9) |
Gives less flexibility than IVIG | 2 (5) |